GGrantIndex
← Search

A5211: AN ORALLY ADMINISTERED HIV-1 ENTRY INHIBITOR IN HIV TX EXPERIENCED PTS

$14,151M01FY2006RRNIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications & trials

View original record on NIH RePORTER →